期刊文献+

苯扎贝特降解菌的筛选及降解特性 被引量:3

Isolation of a bacterial strain capable of bezafibrate-degrading and biodegradation characteristics
原文传递
导出
摘要 【目的】药品苯扎贝特在水环境中频繁检测出,对环境的潜在危害不容忽视。我们筛选分离降解苯扎贝特的细菌,并研究其降解特性。【方法】根据分离菌株的细胞形态结构、生理生化特征及其16S rRNA基因序列分析鉴定降解菌,高效液相色谱法测定苯扎贝特,以判定该菌株的降解能力。【结果】分离菌株B-31属恶臭假单胞菌(Pseudomonas putida),降解机制是共代谢。降解最佳条件为30℃、pH7。此条件下,以1%甲醇为初级基质,30mg/L苯扎贝特的5日降解率为48%。当分别以5g/L葡萄糖、蛋白胨、酵母粉为初级基质时,可使降解率提高到61%,、72.6%、76.67%。【结论】这是国内首次报道恶臭假单胞菌可以通过共代谢降解苯扎贝特,该研究为利用细菌发酵消除水环境中苯扎贝特污染提供基础。 [ Objective] Bezafibrate is one of the most frequently detected pharmaceuticals at relatively high concentration in surface water and even in drinking water. Biodegradation is an important way to solve the problem. This study aimed to isolate, identify and characterize a bezafibrate-degrading bacterium. [ Methods ] Strain B31 capable of degrading bezafibrate by cometabolism was isolated from activated sludge of sewage treatment plant in Shanghai, China, and identified based on its morphology, physiology and phylogenetic analysis of 16S rRNA sequence. To evaluate the ability of degradation, the concentration of bezafibrate was detected by high performance liquid chromatography. [ Results ] Strain B31 was identified to be closely related to Pseudomonas putida. The optimum condition of degrading bezafibrate was at 30℃ , pH 7. After 5 days, Strain B31 could degrade 30 mg/L bezafibrate by 48% in liquid mineral salt medium with 1% methanol as primary substrate. And the rate of degradation could enhance to 61% , 72.6% , 76.67% , when 5g/L glucose, peptone and yeast extract as primary substrate, respectively. [ Conclusion ] The strain has the potential for bezafibrate hiodegradation.
出处 《微生物学报》 CAS CSCD 北大核心 2010年第6期797-802,共6页 Acta Microbiologica Sinica
基金 教育部新世纪优秀人才支持计划(NECT-07-0175) 上海市基础研究重点项目(08JC1400500) 上海市自然科学基金(10ZR1401100) 教育部博士点基金新教师项目(200802551001) 长江水环境教育部重点实验室开放基金项目(YRWEF08003)~~
关键词 药品和个人护理品 苯扎贝特 生物降解 恶臭假单胞菌 Pharmaceutical and Personal Care Products Bezafibrate Biodegradation Pseudomonas putida
  • 相关文献

参考文献16

  • 1Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology letters, 2002, 131(1 -2): 5-17.
  • 2Fent K, Weston AA, Caminada D. Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 2006, 76(2) : 122-159.
  • 3Onesios KM, Yu JT, Bouwer EJ. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation, 2009, 20 (4) : 441-466.
  • 4Cermola M, Dellagreca M, Iesce MR, Previtera L, Rubino M, Temussi F, Brigante M. Phototransformation of fibrate drugs in aqueous media. Environmental Chemistry Letters, 2005, 3( 1 ): 43-47.
  • 5Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers. Water research, 1998, 32 ( 11 ) : 3245-3260.
  • 6Zuccato E, Castiglioni S, Fanelli R. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. Journal of hazardous materials, 2005, 122(3) : 205-209.
  • 7Jones OA, Lester JN, Voulvoulis N. Pharmaceuticals: a threat to drinking waterT. TRENDS in Biotechnology, 2005, 23(4) : 163-167.
  • 8Rosal R, Rodea-Palomares I, Boltes K, Fernandez-Pi? as F, Leganes F, Gonzalo S, Petre A. Ecotoxicity assessment of lipid regulators in water and biologically treated wastewater using three aquatic organisms. Environmental Science and Pollution Research, 2010, 17 (1) : 135-144.
  • 9Isidori M, Bellotta M, Cangiano M, Parrella A. Estrogenic activity of pharmaceuticals in the aquatic environment. Environment International, 2009, 35 (5) : 826-829.
  • 10Quinn B, Gagne F, Blaise C. An investigation into the acute and chronic toxicity of eleven pharmaceuticals ( and their solvents ) found in wastewater effluent on the cnidarian, Hydra attenuata. The Science of the Total Environment, 2008, 389(2 - 3) : 306-314.

二级参考文献3

  • 1[1]Peter B.Process for the preparation of α-[4-(4-chlorobenzoyl-aminoethyl)-phenoxy]-isobutyric acid[P].US:4370495,1983-01-25.
  • 2[2]Castoldi D,Monzani V,Tofanetti O.Determination of bezafibrate in human plasma and urine by high-performance liquid chromatography[J].J.Chromatogr.,1985,344:259-265.
  • 3[3]Lucas D M,Luis A C.Determination of bezafibrate,ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography[J].J.Chromatogr.,1996,687:437-442.

共引文献4

同被引文献34

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部